Kiromic BioPharma Inc.

AI Score

0

Unlock

1.50
0.00 (0.00%)
At close: Feb 28, 2025, 3:17 PM
0.00
-100.00%
After-hours: Dec 31, 1969, 07:00 PM EST

Kiromic BioPharma Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Net Income -26.9M -20.95M -34.73M -25.59M -19.2M -3.73M -3.82M
Depreciation & Amortization 2.23M 2.22M 1.67M 469.8K 200K 87.5K 80.9K
Stock-Based Compensation 597K 141.3K 1.24M 3.76M 13.25M 522.9K 633K
Other Working Capital -339K 1.82M 562.9K -710.6K -386.8K -25.6K 320.2K
Other Non-Cash Items 4.41M 574.8K 3.7M 324.2K 200.00 20.5K 633.1K
Deferred Income Tax n/a n/a n/a n/a 22.2K n/a n/a
Change in Working Capital 198K -3.21M 4.37M 710.3K -394.5K 183.1K 315.8K
Operating Cash Flow -19.46M -21.23M -23.75M -20.32M -6.13M -2.91M -2.15M
Capital Expenditures -366K -206.6K -4.88M -1.89M -1.46M -302.7K -137.3K
Acquisitions n/a n/a 15K 84K n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a 15K -372K n/a n/a n/a
Investing Cash Flow -366K -206.6K -4.87M -1.81M -1.46M -302.7K -137.3K
Debt Repayment n/a 23.44M 4.1M 92.2K 468K 250K 725K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 18.41M -111.2K -200K -2.76M 3M 4.51M 900K
Financial Cash Flow 18.41M 23.99M 3.9M 37.34M 15.81M 4.76M 1.63M
Net Cash Flow -1.41M 2.56M -24.71M 15.2M 8.22M 1.54M -665.2K
Free Cash Flow -19.82M -21.43M -28.63M -22.22M -7.58M -3.22M -2.29M